New Insights on Organ Preservation in Rectal Cancer

Organ preservation strategies in rectal cancer management are safe and effective.

26% of patients underwent organ preservation, with higher rates in early-stage cases (51% vs. 18.1%).
Watch and wait was used for 78% of these patients, showing similar short-term outcomes to local excision.
At 2 years, overall survival exceeded 95% across the board, with no significant differences in disease-free or local recurrence-free survival.

Surgeons should consider these options to tailor treatment based on patient response, particularly in non-metastatic cases.

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

Ann Surg Oncol2 Nov 2026

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

JAMA Surg30 Oct 2026

For severe slow-transit constipation, removing less colon gave similar symptom relief at one year, with less early incontinence.

Surg Endosc29 Oct 2026

In low rectal cancer surgery, removing the specimen through the anus was linked to fewer wound complications and less pain in the first two days.